David P. Bonita - Dec 21, 2021 Form 4 Insider Report for Ikena Oncology, Inc. (IKNA)

Role
Director
Signature
/s/ Douglas R. Carlson, as Attorney-in-Fact for David P. Bonita
Stock symbol
IKNA
Transactions as of
Dec 21, 2021
Transactions value $
$0
Form type
4
Date filed
12/23/2021, 05:28 PM
Previous filing
Nov 17, 2021
Next filing
May 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IKNA Stock Option (Right to Buy) Award $0 +13.4K $0.00 13.4K Dec 21, 2021 Common Stock 13.4K $14.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest (1) 25% on December 21, 2022, and the remaining shall vest in equal monthly installments over the next 36 months.